Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 7/2018

Content (15 Articles)

Open Access Review

Quantifying tumor-infiltrating immune cells from transcriptomics data

Francesca Finotello, Zlatko Trajanoski

Original Article

Depleted polymorphonuclear leukocytes in human metastatic liver reflect an altered immune microenvironment associated with recurrent metastasis

Fiona Hand, Cathal Harmon, Louise A. Elliott, Francesco Caiazza, Aonghus Lavelle, Donal Maguire, Emir Hoti, Niamh Nolan, Justin G. Geoghegan, Elizabeth J. Ryan, Cliona O’Farrelly

Original Article

Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia

Franziska Blaeschke, Dana Stenger, Theresa Kaeuferle, Semjon Willier, Ramin Lotfi, Andrew Didier Kaiser, Mario Assenmacher, Michaela Döring, Judith Feucht, Tobias Feuchtinger

Open Access Original Article

Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APCmin/+ mice

Paulina Akeus, Louis Szeponik, Filip Ahlmanner, Patrik Sundström, Samuel Alsén, Bengt Gustavsson, Tim Sparwasser, Sukanya Raghavan, Marianne Quiding-Järbrink

Open Access Original Article

The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions

Tong Zhang, Xiaomin Song, Lanlan Xu, Jie Ma, Yanjuan Zhang, Wenfeng Gong, Yilu Zhang, Xiaosui Zhou, Zuobai Wang, Yali Wang, Yingdi Shi, Huichen Bai, Ning Liu, Xiaolong Yang, Xinxin Cui, Yanping Cao, Qi Liu, Jing Song, Yucheng Li, Zhiyu Tang, Mingming Guo, Lai Wang, Kang Li

Original Article

Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice

Hussein Sultan, Juan Wu, Takumi Kumai, Andres M. Salazar, Esteban Celis

Open Access Original Article

Pushing the limits of immune-related response: a case of “extreme pseudoprogression”

Alvin S. Wong, Yee-Liang Thian, Jeevesh Kapur, Cheng-Nang Leong, Patrick Kee, Chun-Tsu Lee, Martin B. Lee

Original Article

VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival

Lawrence F. Kuklinski, Shaofeng Yan, Zhongze Li, Jan L. Fisher, Chao Cheng, Randolph J. Noelle, Christina V. Angeles, Mary Jo Turk, Marc S. Ernstoff

Original Article

Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma

Wei Wang, Hanna M. Ollila, Alice S. Whittemore, Shadmehr Demehri, Nilah M. Ioannidis, Eric Jorgenson, Emmanuel Mignot, Maryam M. Asgari

Original Article

Novel non-invasive early detection of lung cancer using liquid immunobiopsy metabolic activity profiles

Yochai Adir, Shoval Tirman, Shirley Abramovitch, Cynthia Botbol, Aviv Lutaty, Tali Scheinmann, Eyal Davidovits, Irit Arbel, Giora Davidovits, Sonia Schneer, Michal Shteinberg, Hagit Peretz Soroka, Ruven Tirosh, Fernando Patolsky

Original Article

T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin

Corinne Bauer, Ashik Ahmed Abdul Pari, Viktor Umansky, Jochen Utikal, Petra Boukamp, Hellmut G. Augustin, Sergij Goerdt, Cyrill Géraud, Moritz Felcht

Original Article

Regulatory NK1.1−CD4+NKG2D+ subset induced by NKG2DL+ cells promotes tumor evasion in mice

Zhijie Lin, Sen Han, Xingxing Qian, Chunxia Hu, Weiming Xiao, Li Qian, Yu Zhang, Yanbing Ding, Xiaoqin Jia, Guoqiang Zhu, Weijuan Gong

Letter to the Editors

The role of myeloid derived suppressor cells in mycosis fungoides

Alessandro Pileri, Claudio Agostinelli, Pietro Quaglino, Annalisa Patrizi, Nicola Pimpinelli

Letter to the Editors

Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides

Larisa J. Geskin, Oleg E. Akilov, Michael K. Schowalter, Louis D. Falo Jr.

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine